P E Stieg

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat
    P E Stieg
    CNS Research Institute, Neurosurgical Service, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Eur J Pharmacol 375:115-20. 1999

Collaborators

Detail Information

Publications1

  1. ncbi Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat
    P E Stieg
    CNS Research Institute, Neurosurgical Service, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Eur J Pharmacol 375:115-20. 1999
    ..0001). At this dosage, memantine manifests few, if any, neurobehavioral side effects. Thus memantine appears to be both safe and effective in neonatal as well as adult animal models of stroke...